Terms: = Leukemia AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Treatment
93 results:
1. Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of
Levis MJ; Hamadani M; Logan B; Jones RJ; Singh AK; Litzow M; Wingard JR; Papadopoulos EB; Perl AE; Soiffer RJ; Ustun C; Ueda Oshima M; Uy GL; Waller EK; Vasu S; Solh M; Mishra A; Muffly L; Kim HJ; Mikesch JH; Najima Y; Onozawa M; Thomson K; Nagler A; Wei AH; Marcucci G; Geller NL; Hasabou N; Delgado D; Rosales M; Hill J; Gill SC; Nuthethi R; King D; Wittsack H; Mendizabal A; Devine SM; Horowitz MM; Chen YB;
J Clin Oncol; 2024 May; 42(15):1766-1775. PubMed ID: 38471061
[TBL] [Abstract] [Full Text] [Related]
2. HLA-B*58 and HLA-B*27 Play a Role in the Development of Acute leukemia: A Case Control Study.
Habour Nouar N; Yafour N; Youcef BY; Bouhass R; Chekkal M; Brahimi M; Bekadja MA; Sahraoui T
Asian Pac J Cancer Prev; 2024 Jan; 25(1):169-173. PubMed ID: 38285781
[TBL] [Abstract] [Full Text] [Related]
3. Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1.
Hu C; Fu X; Li S; Chen C; Zhao X; Peng J
Daru; 2024 Jun; 32(1):11-24. PubMed ID: 37926762
[TBL] [Abstract] [Full Text] [Related]
4. [A comparative study of the effects of citrate and heparin anticoagulation on coagulation function and efficacy in children with septic shock undergoing continuous blood purification].
Zhong X; Luo S; Ren R; Lai J; Deng G; Zhu H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):856-859. PubMed ID: 37593866
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA SNHG1 Accelerates Cell Proliferation, Migration, and Invasion of Hepatoblastoma Through Mediating miR-6838-5p/PIM3/rhoa Axis.
Zhang T; Ji C; Zhang Y; Yuan M; Gao H; Yin Q
Biochem Genet; 2024 Feb; 62(1):59-76. PubMed ID: 37248373
[TBL] [Abstract] [Full Text] [Related]
6. Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
Ruan J; Moskowitz A; Mehta-Shah N; Sokol L; Chen Z; Kotlov N; Nos G; Sorokina M; Maksimov V; Sboner A; Sigouros M; van Besien K; Horwitz S; Rutherford SC; Mulvey E; Revuelta MV; Xiang J; Alonso A; Melnick A; Elemento O; Inghirami G; Leonard JP; Cerchietti L; Martin P
Blood; 2023 May; 141(18):2194-2205. PubMed ID: 36796016
[TBL] [Abstract] [Full Text] [Related]
7. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma.
Kameda T; Kataoka K; Kamiunten A; Hidaka M; Miyoshi H; Nakano N; Nosaka K; Yoshimitsu M; Yasunaga JI; Kogure Y; Shide K; Miyahara M; Sakamoto T; Akizuki K; Hidaka T; Kubuki Y; Koya J; Kawano N; Yamashita K; Kawano H; Toyama T; Maeda K; Marutsuka K; Imaizumi Y; Kato K; Sugio T; Tokunaga M; Tashiro Y; Takaori-Kondo A; Miyazaki Y; Akashi K; Ishitsuka K; Matsuoka M; Ohshima K; Watanabe T; Kitanaka A; Utsunomiya A; Ogawa S; Shimoda K
Haematologica; 2023 Aug; 108(8):2178-2191. PubMed ID: 36794502
[TBL] [Abstract] [Full Text] [Related]
8. Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021.
Gill H; Raghupathy R; Lee CYY; Yung Y; Chu HT; Ni MY; Xiao X; Flores FP; Yim R; Lee P; Chin L; Li VWK; Au L; Au WY; Ma ESK; Mohan D; Kumana CR; Kwong YL
BMC Cancer; 2023 Feb; 23(1):141. PubMed ID: 36765318
[TBL] [Abstract] [Full Text] [Related]
9. Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial.
Burke GAA; Vinti L; Kabickova E; Beishuizen A; Tacyildiz N; Uyttebroeck A; Kang HJ; Luisi F; Minard-Colin V; Burkhardt B; Tamegnon M; Sun S; Curtis M; Deshpande S; Nottage K; Howes A; Srinivasan S; Bhojwani D; Norris R; Cairo M
Blood Adv; 2023 Feb; 7(4):602-610. PubMed ID: 36541957
[TBL] [Abstract] [Full Text] [Related]
10. PAR4-Mediated PI3K/Akt and rhoa/ROCK Signaling Pathways Are Essential for Thrombin-Induced Morphological Changes in MEG-01 Cells.
Heo Y; Jeon H; Namkung W
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054966
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic Significance of Long Non Coding RNA ANRIL and SNHG14 in Acute Myeloid leukemia.
Gamaleldin MA; Ghallab O; Abo Elwafa RA
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3763-3771. PubMed ID: 34967554
[TBL] [Abstract] [Full Text] [Related]
12. Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and rhoa/ROCK pathways in acute myeloid leukemia.
Liang X; Xia R
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34792179
[TBL] [Abstract] [Full Text] [Related]
13. Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis.
Narendra G; Raju B; Verma H; Silakari O
Med Oncol; 2021 Sep; 38(10):123. PubMed ID: 34491453
[TBL] [Abstract] [Full Text] [Related]
14. The long noncoding RNA HOTAIRM1 controlled by AML1 enhances glucocorticoid resistance by activating rhoa/ROCK1 pathway through suppressing ARHGAP18.
Liang L; Gu W; Li M; Gao R; Zhang X; Guo C; Mi S
Cell Death Dis; 2021 Jul; 12(7):702. PubMed ID: 34262023
[TBL] [Abstract] [Full Text] [Related]
15. Activation of Protein Tyrosine Phosphatase Receptor Type γ Suppresses Mechanisms of Adhesion and Survival in Chronic Lymphocytic leukemia Cells.
Montresor A; Toffali L; Fumagalli L; Constantin G; Rigo A; Ferrarini I; Vinante F; Laudanna C
J Immunol; 2021 Jul; 207(2):671-684. PubMed ID: 34162728
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial.
Kimura SI; Kanda Y; Iino M; Fukuda T; Sakaida E; Oyake T; Yamaguchi H; Fujiwara SI; Jo Y; Okamoto A; Fujita H; Takamatsu Y; Saburi Y; Matsumura I; Yamanouchi J; Shiratori S; Gotoh M; Nakamura S; Tamura K;
Int J Infect Dis; 2020 Nov; 100():292-297. PubMed ID: 32891738
[TBL] [Abstract] [Full Text] [Related]
17. Parental education and cancer mortality in children, adolescents, and young adults: A case-cohort study within the 2011 Italian census cohort.
Alicandro G; Bertuccio P; Sebastiani G; La Vecchia C; Frova L
Cancer; 2020 Nov; 126(21):4753-4760. PubMed ID: 32809229
[TBL] [Abstract] [Full Text] [Related]
18. leukemia-Associated Rho Guanine Nucleotide Exchange Factor and Ras Homolog Family Member C Play a Role in Glioblastoma Cell Invasion and Resistance.
Ding Z; Dong Z; Yang Y; Fortin Ensign SP; Sabit H; Nakada M; Ruggieri R; Kloss JM; Symons M; Tran NL; Loftus JC
Am J Pathol; 2020 Oct; 190(10):2165-2176. PubMed ID: 32693062
[TBL] [Abstract] [Full Text] [Related]
19. Clinical heterogeneity under induction with different dosages of cytarabine in core binding factor acute myeloid leukaemia.
Wang B; Zhang J; Hua X; Li H; Wang Z; Yang B
Sci Rep; 2020 Jan; 10(1):685. PubMed ID: 31959790
[TBL] [Abstract] [Full Text] [Related]
20. ARHGEF12 regulates erythropoiesis and is involved in erythroid regeneration after chemotherapy in acute lymphoblastic leukemia patients.
Xie Y; Gao L; Xu C; Chu L; Gao L; Wu R; Liu Y; Liu T; Sun XJ; Ren R; Tang J; Zheng Y; Zhou Y; Shen S
Haematologica; 2020 Apr; 105(4):925-936. PubMed ID: 31467124
[TBL] [Abstract] [Full Text] [Related]
[Next]
